Spots Global Cancer Trial Database for glivec
Every month we try and update this database with for glivec cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination | NCT01613053 | Gastrointestina... | Glivec | 18 Years - | Novartis | |
| Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct | NCT01153750 | Advanced or Met... | Glivec | 18 Years - | University Hospital Dresden | |
| Glivec in Ph Positive Lymphoblastic Leukemia | NCT00388895 | Acute Lymphobla... Cromosome Phila... | chemotherapy Glivec | - 65 Years | PETHEMA Foundation | |
| Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML) | NCT00744081 | AML | Glivec Mitoxantrone Topotecan AraC | 18 Years - | Goethe University | |
| Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body | NCT01795716 | Chronic Myeloid... | mesylate imatin... Glivec | 18 Years - 65 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML) | NCT00744081 | AML | Glivec Mitoxantrone Topotecan AraC | 18 Years - | Goethe University | |
| Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML) | NCT00744081 | AML | Glivec Mitoxantrone Topotecan AraC | 18 Years - | Goethe University | |
| Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia | NCT00079313 | Chronic Myelomo... Chronic Myeloge... | Imatinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body | NCT01795716 | Chronic Myeloid... | mesylate imatin... Glivec | 18 Years - 65 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct | NCT01153750 | Advanced or Met... | Glivec | 18 Years - | University Hospital Dresden | |
| Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors | NCT00293124 | Gastrointestina... | Glivec | 18 Years - | Central European Cooperative Oncology Group | |
| Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia | NCT00390897 | Chronic Myeloid... | Glivec Interferon | 18 Years - 72 Years | PETHEMA Foundation | |
| Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. | NCT00159016 | Metastatic Soli... | Glivec | 18 Years - | Hadassah Medical Organization | |
| Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML) | NCT00744081 | AML | Glivec Mitoxantrone Topotecan AraC | 18 Years - | Goethe University | |
| Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. | NCT00159016 | Metastatic Soli... | Glivec | 18 Years - | Hadassah Medical Organization | |
| Glivec Phase II Pediatric Study | NCT00180830 | Cancer | Glivec Gleevec | 6 Months - 21 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Glivec in Ph Positive Lymphoblastic Leukemia | NCT00388895 | Acute Lymphobla... Cromosome Phila... | chemotherapy Glivec | - 65 Years | PETHEMA Foundation | |
| Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia | NCT00390897 | Chronic Myeloid... | Glivec Interferon | 18 Years - 72 Years | PETHEMA Foundation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
